HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 34 filers reported holding HARPOON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,206,000 | -21.7% | 190,483 | 0.0% | 0.21% | -8.5% |
| Q4 2019 | $2,817,000 | -36.2% | 190,483 | -41.1% | 0.23% | -52.2% |
| Q3 2019 | $4,418,000 | +5.1% | 323,400 | 0.0% | 0.49% | +76.3% |
| Q2 2019 | $4,205,000 | +37.3% | 323,400 | 0.0% | 0.28% | +42.6% |
| Q1 2019 | $3,062,000 | – | 323,400 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $66,916,000 | 29.45% |
| MPM BioImpact LLC | 3,898,422 | $57,658,000 | 20.43% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $43,208,000 | 9.39% |
| Soleus Capital Management, L.P. | 123,200 | $1,822,000 | 1.76% |
| EcoR1 Capital, LLC | 908,547 | $13,437,000 | 1.21% |
| Orbimed Advisors | 2,446,409 | $36,182,000 | 0.52% |
| Artal Group S.A. | 850,000 | $12,572,000 | 0.49% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,031 | $5,680,000 | 0.47% |
| Cormorant Asset Management, LP | 649,994 | $9,613,000 | 0.38% |
| Fosun International Ltd | 190,483 | $2,817,000 | 0.23% |